XCHC Gets Set to Launch its Cannabinoid Based Phytiva European Brand Product Line, Issues Positive Update on Internal Technology Upgrades and Marketing Developments
DALLAS, Feb. 21, 2013 /PRNewswire/ — X-Change Corp. (NASDAQ OTC: XCHC), a patient based U.S. company targeting critical and non-critical ailments through the use of Cannabinoid based formulations, extracts and products through multiple Phytiva Brand product lines and solutions, gets set to launch its initial Cannabinoid based Phytiva European product line. Official launch dates, premier launch party, and other media event dates will be announced shortly.
Phytiva’s European Cannabinoid based product line will include Lip Balms, Moisturizing Cremes, After Sun Gels, Sunscreens, Anti-Aging Serums, and Gel Caps. The line will be available on the Phytiva website internationally and through other distribution channels. The Phytiva European Brand line will be marketed through commercials, infomercials, and advertisements, which are already in production stage and are expected to coincide with the product launch.
As additional Cannabinoid products in the Phytiva European line are being added to the roll-out, marketing through commercial and infomercial production will keep pace with product line additions throughout the first and second quarters. This aggressive, international marketing effort is expected to be one of the first campaigns showcasing a Cannabinoid based product line.
X-Change Corp also announces upgrades to its internal systems to lower operational costs and increase efficiency over time. These improved systems range from the Company’s online retail store to an extensive wholesale operation utilizing Company databases. Communicating with retail, wholesale, and other interested parties is planned to maximize the effect of the Phytiva marketing strategy, including the use of a tailored communications and email push to share press releases, product announcements, and other industry insights. The Company welcomes broad participation. Interested parties may be placed in the email database with a request sent to email@example.com.
“Two items on the top of our list are to ramp up communication and marketing and to make the Phytiva Brand of products available to the public in an efficient manner. The development of the database and the online store are two critical milestones, as we prepare for the launch of Phytiva’s initial European product line. As President of the Company, I want to congratulate the Phytiva team, particularly Mr. Dupetit in Germany and Mr. Young here in the U.S., for doing an incredible job preparing for the launch,” stated Robert Kane, President of X-Change Corp.
About Phytiva Brand Product Lines
Phytiva expects to develop and launch various innovative product lines. The first is the Phytiva Brand European Line, which is an inventive line that is a hybrid of a proven, existing product line that has been well-managed and conservatively-run for over a decade with a Cannabinoid based product line, utilizing the unique and potent benefits of Cannabinoids. Phytiva’s revolutionary formulations target not just the symptom, but also the cause. Cannabinoids are an ideal base for therapeutic solutions and has been utilized for centuries, as skin responds extremely well to its properties.
Phytiva strives to be one of the quintessential cosmeceutical and nutraceutical brands in the world. As cosmetics and nutrition are personal, over-the-counter markets, they continuously evolve with the introduction of new formulations and products, creating a multibillion-dollar global market opportunity. The Company believes that Phytiva’s lines will capture a substantial and profitable portion of that market, as Phytiva becomes a household name.
About The X-Change Corporation
X-Change Corp. is U.S. Boutique Company whose niche is Cannabinoid based extracts and products that target medical cannabis, cosmeceutical, nutraceutical, and social usage solutions through multiple Phytiva Brand product lines, products, and services. These new Phytiva product lines will be launched with Cannabinoid based formulations through a combination of retail and wholesale products, medical cannabis dispensaries, cannabis research in clinics and laboratories as announced, for example, with the Maliseet Nation in Canada, and other individual legal state or legal foreign grow operations on a jurisdiction by jurisdiction approved basis.
Forward Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as “anticipate,” “seek,” intend,” “believe,” “plan,” “estimate,” “expect,” “project,” “plan,” or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. X-Change Corp. does not undertake any duty nor does it intend to update the results of these forward-looking statements.
President & CEO
SOURCE X-Change Corp.